Personalis (PSNL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $15.65, -1.76% vs the prior close of $15.93.
- Volume 3.30M shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PSNL dips 1.8% to $15.65, a 1-month low. Closed at $15.65, -1.76% vs the prior close of $15.93. Day range $15.51–$16.00, opened at $15.86.
PSNL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PSNL dips 1.8% to $15.65, a 1-month low
- Closed at $15.65, -1.76% vs the prior close of $15.93. Day range $15.51–$16.00, opened at $15.86.
- Volume was 3.30M shares, 1.1x its 50-day average of 2.88M.
- Price is -2.6% vs its 50-day average ($16.07) and +43.3% vs its 200-day average ($10.92).
- 52-week range $4.95–$18.89; today's close sits at 77% of that range, 17.2% below the 52-week high.
Oct 15, 2026 — PSNL ends flat (+0.2%) to $15.93, 3 up days in a row
- Closed at $15.93, +0.19% vs the prior close of $15.90. Day range $15.83–$16.08, opened at $15.88.
- Volume was 2.14M shares, 0.7x its 50-day average of 2.86M.
- Price is -0.6% vs its 50-day average ($16.02) and +46.4% vs its 200-day average ($10.88).
- 52-week range $4.95–$18.89; today's close sits at 79% of that range, 15.7% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — PSNL rises 0.3% to $15.90
- Closed at $15.90, +0.32% vs the prior close of $15.85. Day range $15.68–$16.00, opened at $15.71.
- Volume was 3.26M shares, 1.2x its 50-day average of 2.83M.
- Price is -0.5% vs its 50-day average ($15.97) and +46.7% vs its 200-day average ($10.84).
- 52-week range $4.95–$18.89; today's close sits at 79% of that range, 15.8% below the 52-week high.
Oct 13, 2026 — PSNL rises 0.3% to $15.85
- Closed at $15.85, +0.32% vs the prior close of $15.80. Day range $15.79–$15.97, opened at $15.82.
- Volume was 3.82M shares, 1.3x its 50-day average of 2.85M.
- Price is -0.5% vs its 50-day average ($15.93) and +46.7% vs its 200-day average ($10.80).
- 52-week range $4.95–$18.89; today's close sits at 78% of that range, 16.1% below the 52-week high.
Oct 12, 2026 — PSNL dips 1.2% to $15.80, a 1-month low
- Closed at $15.80, -1.25% vs the prior close of $16.00. Day range $15.80–$16.17, opened at $16.01.
- Volume was 2.25M shares, 0.8x its 50-day average of 2.86M.
- Price is -0.5% vs its 50-day average ($15.87) and +46.8% vs its 200-day average ($10.76).
- 52-week range $4.95–$18.89; today's close sits at 78% of that range, 16.4% below the 52-week high.
Oct 9, 2026 — PSNL dips 0.4% to $16.00
- Closed at $16.00, -0.37% vs the prior close of $16.06. Day range $15.98–$16.24, opened at $16.19.
- Volume was 1.84M shares, 0.6x its 50-day average of 2.88M.
- Price is +1.2% vs its 50-day average ($15.81) and +49.2% vs its 200-day average ($10.73).
- 52-week range $4.95–$18.89; today's close sits at 79% of that range, 15.3% below the 52-week high.
Oct 8, 2026 — PSNL rises 0.4% to $16.06
- Closed at $16.06, +0.37% vs the prior close of $16.00. Day range $15.92–$16.20, opened at $15.92.
- Volume was 1.47M shares, 0.5x its 50-day average of 2.89M — lighter than usual.
- Price is +2.1% vs its 50-day average ($15.74) and +50.2% vs its 200-day average ($10.69).
- 52-week range $4.95–$18.89; today's close sits at 80% of that range, 15.0% below the 52-week high.
Oct 7, 2026 — PSNL ends flat (-0.2%) to $16.00, a 1-month low
- Closed at $16.00, -0.19% vs the prior close of $16.03. Day range $15.68–$16.10, opened at $15.77.
- Volume was 3.82M shares, 1.3x its 50-day average of 2.87M.
- Price is +2.2% vs its 50-day average ($15.65) and +50.2% vs its 200-day average ($10.65).
- 52-week range $4.95–$18.89; today's close sits at 79% of that range, 15.3% below the 52-week high.
Oct 6, 2026 — PSNL dips 2.3% to $16.03, a 1-month low on 2.0x normal volume
- Closed at $16.03, -2.26% vs the prior close of $16.40. Day range $15.84–$16.58, opened at $16.25.
- Volume was 5.66M shares, 2.0x its 50-day average of 2.85M — unusually heavy trading.
- Price is +3.0% vs its 50-day average ($15.57) and +51.0% vs its 200-day average ($10.61).
- 52-week range $4.95–$18.89; today's close sits at 79% of that range, 15.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — PSNL rises 0.7% to $16.40
- Closed at $16.40, +0.74% vs the prior close of $16.28. Day range $16.02–$16.47, opened at $16.12.
- Volume was 1.70M shares, 0.6x its 50-day average of 2.88M — lighter than usual.
- Price is +5.9% vs its 50-day average ($15.49) and +55.1% vs its 200-day average ($10.57).
- 52-week range $4.95–$18.89; today's close sits at 82% of that range, 13.2% below the 52-week high.
Oct 2, 2026 — PSNL rises 0.7% to $16.28
- Closed at $16.28, +0.68% vs the prior close of $16.17. Day range $16.12–$16.44, opened at $16.38.
- Volume was 1.14M shares, 0.4x its 50-day average of 2.93M — lighter than usual.
- Price is +5.8% vs its 50-day average ($15.39) and +54.6% vs its 200-day average ($10.53).
- 52-week range $4.95–$18.89; today's close sits at 81% of that range, 13.8% below the 52-week high.
PSNL latest news & SEC filings
Every SEC filing by or about PSNL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 2, 2026 · Form SC 13E3/A — SC 13E3/A filing
SC 13E3/A filing
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form CT ORDER — CT ORDER filing
CT ORDER filing
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moore Stephen Michael sold 2,068 shares at $16.22 (≈$33.54K) on Sep 18, 2026; now holds 90,257
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Richard sold 3,998 shares at $16.22 (≈$64.85K) on Sep 18, 2026; now holds 169,882
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hall Christopher M sold 7,459 shares at $16.22 (≈$120.98K) on Sep 18, 2026; now holds 228,527
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tachibana Aaron sold 2,931 shares at $16.22 (≈$47.54K) on Sep 18, 2026; now holds 195,902
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form SC 13E3 — SC 13E3 filing
SC 13E3 filing
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $22.36M (prior year $17.20M) (+30.0% vs Jun 30, 2025)
- Net income: -$31.68M (prior year -$20.06M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.30 (prior year -$0.23) (loss widened vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade PSNL
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: Jul 20, 2026, May 7, 2026, Feb 26, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.72% (largest 2.3%). That is a relatively calm stock.
- Liquidity: about 2.14M shares (≈$33.48M) trade per day on average.
- 52-week position: $15.65 vs a range of $4.95–$18.89 (77% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Stephen Michael Moore sold 2,068 shares on Sep 18, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Aug 20, 2026; 10-Q Aug 4, 2026.
- Share count: 106.80M shares outstanding (Jul 29, 2026), +20.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
PSNL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 15.86 | 16.00 | 15.51 | 15.65 | 3.30M |
| Oct 15, 2026 | 15.88 | 16.08 | 15.83 | 15.93 | 2.14M |
| Oct 14, 2026 | 15.71 | 16.00 | 15.68 | 15.90 | 3.26M |
| Oct 13, 2026 | 15.82 | 15.97 | 15.79 | 15.85 | 3.82M |
| Oct 12, 2026 | 16.01 | 16.17 | 15.80 | 15.80 | 2.25M |
| Oct 9, 2026 | 16.19 | 16.24 | 15.98 | 16.00 | 1.84M |
| Oct 8, 2026 | 15.92 | 16.20 | 15.92 | 16.06 | 1.47M |
| Oct 7, 2026 | 15.77 | 16.10 | 15.68 | 16.00 | 3.82M |
| Oct 6, 2026 | 16.25 | 16.58 | 15.84 | 16.03 | 5.66M |
| Oct 5, 2026 | 16.12 | 16.47 | 16.02 | 16.40 | 1.70M |
| Oct 2, 2026 | 16.38 | 16.44 | 16.12 | 16.28 | 1.14M |
| Oct 1, 2026 | 16.22 | 16.32 | 16.07 | 16.17 | 1.66M |
| Sep 30, 2026 | 16.42 | 16.59 | 16.26 | 16.28 | 981.40K |
| Sep 29, 2026 | 16.25 | 16.47 | 16.08 | 16.35 | 1.04M |
| Sep 28, 2026 | 16.22 | 16.48 | 16.00 | 16.32 | 1.67M |
| Sep 25, 2026 | 16.74 | 16.77 | 16.38 | 16.46 | 1.01M |
| Sep 24, 2026 | 16.16 | 16.63 | 16.10 | 16.57 | 1.71M |
| Sep 23, 2026 | 16.16 | 16.42 | 16.09 | 16.35 | 1.12M |
| Sep 22, 2026 | 16.29 | 16.48 | 16.13 | 16.36 | 1.37M |
| Sep 21, 2026 | 16.38 | 16.50 | 16.07 | 16.24 | 1.82M |
About Personalis
Personalis (PSNL) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in FREMONT, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1527753.
PSNL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| A Blaine Bowman | Director | May 14, 2026 |
| Olivia Kyusuk Bloom | Director | May 14, 2026 |
| Karin Eastham | Director | Jun 11, 2026 |
| Christopher M Hall | Chief Executive Officer | Sep 22, 2026 |
| Woodrow A Jr Myers | Director | May 14, 2026 |
| Lonnie Shoff | Director | May 14, 2026 |
| Kenneth J Widder | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Richard Chen | President and CMO | Sep 22, 2026 |
| Christopher M Hall | Chief Executive Officer | Sep 22, 2026 |
| Stephen Michael Moore | SVP and Chief Legal Officer | Sep 22, 2026 |
| Aaron Tachibana | CFO AND COO | Sep 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Stephen Michael Moore | Sale | 2,068 | $16.22 |
| Sep 18, 2026 | Stephen Michael Moore | Sale | 2,068 | $16.22 |
| Sep 18, 2026 | Stephen Michael Moore | Sale | 2,068 | $16.22 |
| Sep 18, 2026 | Stephen Michael Moore | Sale | 2,068 | $16.22 |
| Sep 18, 2026 | Richard Chen | Sale | 3,998 | $16.22 |
| Sep 18, 2026 | Richard Chen | Sale | 3,998 | $16.22 |
| Sep 18, 2026 | Richard Chen | Sale | 3,998 | $16.22 |
| Sep 18, 2026 | Richard Chen | Sale | 3,998 | $16.22 |
| Sep 18, 2026 | Aaron Tachibana | Sale | 2,931 | $16.22 |
| Sep 18, 2026 | Aaron Tachibana | Sale | 2,931 | $16.22 |
| Sep 18, 2026 | Aaron Tachibana | Sale | 2,931 | $16.22 |
| Sep 18, 2026 | Aaron Tachibana | Sale | 2,931 | $16.22 |
| Sep 18, 2026 | Christopher M Hall | Sale | 7,459 | $16.22 |
| Sep 18, 2026 | Christopher M Hall | Sale | 7,459 | $16.22 |
| Sep 18, 2026 | Christopher M Hall | Sale | 7,459 | $16.22 |
PSNL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $69.65M | $-81.27M | -0.91 | $-74.95M |
| Dec 31, 2024 | $84.61M | $-81.28M | -1.37 | $-45.15M |
| Dec 31, 2023 | $73.48M | $-108.30M | -2.25 | $-56.26M |
| Dec 31, 2022 | $65.05M | $-113.31M | -2.48 | $-70.23M |
| Dec 31, 2021 | $85.49M | $-65.23M | -1.49 | $-70.83M |
Latest balance sheet: total assets $312.13M, total liabilities $76.97M, cash $93.97M (as of Jun 30, 2026).
PSNL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $13.52 |
| Jul 20, 2026 | 8-K Item 2.02 (results) | $13.34 |
| May 7, 2026 | 8-K Item 2.02 (results) | $5.99 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $9.03 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $8.38 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $8.73 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $5.64 |
| May 6, 2025 | 8-K Item 2.02 (results) | $4.00 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $4.24 |
| Jan 7, 2025 | 8-K Item 2.02 (results) | $5.98 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $5.58 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PSNL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.